IntrinsicIntrinsic
← Scroll for more →

Financial Statements — NXNT

Balance Sheet

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
Cash & Equivalents0.750.490.060.030.020.080.150.080.170.240.44
Accounts Receivable--0.49------------------
Total Current Assets0.811.290.100.120.030.080.160.100.230.240.44
Property, Plant & Equipment--0.21------------------
Goodwill--2.58------------------
Intangible Assets--0.19------------------
Total Non-current Assets*0.173.390.140.170.150.020.020.020.000.000.00
Total Assets0.984.680.240.290.180.090.180.120.230.240.44
Accounts Payable0.030.040.010.030.010.010.030.020.010.010.01
Short-term Debt--1.73------------------
Total Current Liabilities0.621.780.100.490.050.030.050.040.010.010.01
Long-term Debt--0.11------------------
Total Non-current Liabilities*0.230.760.560.300.340.270.180.010.000.000.00
Total Liabilities0.852.540.670.780.400.300.230.040.010.010.01
Retained Earnings(2.00)(2.44)(1.73)(1.88)(1.45)(1.32)(1.16)(1.03)(0.77)(0.55)(0.34)
Total Stockholder Equity0.132.14(0.43)(0.50)(0.22)(0.21)(0.05)0.080.220.230.43
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
Total Revenue0.001.110.00--0.000.000.000.000.000.000.00
Cost of Revenue--0.67------------------
Gross Profit--0.44------------------
Research & Development0.010.020.01--0.000.010.070.080.060.050.02
Selling, General & Admin0.110.660.14--0.110.150.060.180.160.170.23
Total Operating Expenses0.120.820.15--0.110.160.130.260.220.220.24
Operating Income--(0.38)------------------
Interest Expense--0.010.01----------------
Pretax Income*--(0.15)------------------
Tax Provision---0.00------------------
Net Income(0.13)(0.15)(0.17)(0.11)(0.13)(0.16)(0.13)(0.26)(0.22)(0.22)(0.24)
Diluted EPS(0.01)(0.01)----(0.01)(0.01)----------
← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in thousands USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
Operating Cash Flow(23.47)(40.49)(91.52)(40.91)(105.15)(157.42)(104.36)(143.65)(178.16)(210.51)(113.13)
Capital Expenditures--39.36------------------
Free Cash Flow*--(79.86)------------------
Investing Cash Flow0.00(614.22)--527.50(47.50)------------
Financing Cash Flow750.0010.0050.00(407.50)95.0085.00180.0050.00104.5017.50346.80
← Scroll for more columns →

* Derived from reported values